Principal Investigator
Janaki Sharma
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251134
Clinical Trial Summary
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Prostate, Bladder, and Kidney Cancers
Contact Information
Phone Number
+1 (305) 2439731